Among different maternal metabolic risk factors, fasting maternal insulin levels in pregnant mothers with obesity at 18-20gw were associated with the abdominal/total FMr in newborns, a known predictor of cardiometabolic risk later in life. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.